Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

CM = contrast media; CO2 = carbon dioxide; Gd = gadolinium; IVUS = intravascular ultrasound. Image courtesy of the Journal of Vascular and Interventional Radiology
News | Contrast Media
Global Contrast Media Shortage Means Urgent Changes in Interventional Radiology Practices

June 23, 2022 — Supply chain disruptions have created critical shortages of Omnipaque (iohexol) and Visipaque (iodixanol ...

Time June 23, 2022
arrow
Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to be close to 100% starting Monday, June 6, following the easing of local COVID-19 restrictions.
News | Contrast Media
GE Healthcare Issues Update on Iodinated Contrast Media

June 2, 2022 — Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to ...

Time June 02, 2022
arrow
Top 10 ITN content for the Month of May 2022
Feature | Radiology Business | By Melinda Taschetta-Millane
ITN's Top 10 Most-read Content for May

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
The current shortage of iodinated contrast in the United States due to the COVID-19 related production shutdown in China is causing severe disruptions in patient care. A new Harvey L. Neiman Health Policy Institute study outlines the most frequently used computed tomography (CT) services performed on Medicare beneficiaries as focus areas for mitigation strategies for the greatest overall impact.
News | Contrast Media
New Study Informs Mitigation Strategies for Contrast Shortage in CT by Identifying Promising Areas of Focus

June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production ...

Time June 01, 2022
arrow
Patented artificial intelligence technology eliminates the need for gadolinium-based contrast agents in MRI exams
News | Artificial Intelligence
Imaging Biometrics Submits FDA 510(k) Application for IB Zero G

May 31, 2022 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, announced it has submitted an FDA 510(k) ...

Time May 31, 2022
arrow
Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare Omnipaque iohexol iodinated contrast media (ICM) for radiologic examinations.
News | Contrast Media
New Report Provides Strategies for Managing Contrast Shortage

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
Decision tree for manual review of currently scheduled contrast-enhanced CT examinations in the event that iodinated contrast supply is critically low. CECT = contrast-enhanced CT. GBCA = gadolinium-based contrast agent. NCCT = non-contrast CT. US = ultrasound.
News | Contrast Media
AJR Publishes Best Practices for Iodinated Contrast Media Shortage

May 18, 2022 —According to ARRS’ American Journal of Roentgenology (AJR), to ensure that patients with emergent or life ...

Time May 18, 2022
arrow
The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware of the current global shortage of iodinated contrast media.
News | Contrast Media
Statement from the ACR Committee on Drugs and Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.
Feature | Contrast Media
Contrast Media/Contrast Agent Market

The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...

Time May 03, 2022
arrow
Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.
Sponsored Content | Case Study | Contrast Media Injectors
Case Studies with Lawrence N. Tanenbaum, MD FACR Using Macrocyclic CLARISCAN (gadoterate meglumine) Injection for Intravenous Use

Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...

Time May 03, 2022
arrow
NEXO[DOSE] dashboard
Sponsored Content | Blog | Radiation Dose Management
Effective Radiation Dose Management Improves Imaging Practices, Patient Safety and Ensures Compliance

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time April 11, 2022
arrow
Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and digital and artificial intelligence (AI) solutions for diagnostic and interventional imaging, has recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and a Centralized Application for Marketing Authorization to the European Medicine Agency (EMA) for Gadopiclenol, an investigational macrocyclic gadolinium-based contrast agent (GBCA).
News | Contrast Media
Gadopiclenol Marketing Authorization Dossier Submissions Accepted for Review by EMA and FDA

April 6, 2022 — Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products ...

Time April 06, 2022
arrow
EmpowerMR Injector System
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Advanced Injector System Provides Greater Control and Accelerates Patient Care

Medical imaging and contrast use have become an integral part of the diagnostic process to determine the best ...

Time February 28, 2022
arrow
Sponsored Content | Sponsored Content | Videos | Contrast Media
Talking Trends with GE Healthcare: Ensuring a Secure and Sustainable Supply Chain

With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...

Time February 23, 2022
arrow
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Patient-centric Injector Solutions Help CT Departments Take Control, Improve Safety

Patient safety is a fundamental requirement to all applications of radiology techniques and procedures. As the ...

Time January 21, 2022
arrow
In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane
Contrast Media Injectors Market Outlook

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have ...

Time January 19, 2022
arrow
The global contrast media market size is expected to reach USD 7.2 billion by 2028 and is expected to expand at a CAGR of 8.6% from 2021 to 2028.
News | Contrast Media
Global Contrast Media Trends and Analysis Report 2021

December 30, 2021 — The "Global Contrast Media Market Size, Share & Trends Analysis Report by Product Type (Iodinated ...

Time December 30, 2021
arrow
Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.
News | Contrast Media Injectors
Qaelum NV and ulrich Medical Enter Into a Strategic Partnership

December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to ...

Time December 13, 2021
arrow
Figure 1. Left image shows breast MRI in 41-year-old patient without IUD. Right image shows increased parenchymal enhancement in the same patient 27 months after IUD placement.
Feature | Radiology Imaging | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in November 2021

December 8, 2021 — Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of November ...

Time December 08, 2021
arrow
Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging, announced a recent boom for DOTAREM (gadoterate meglumine) injection.
News | Contrast Media
Medical Imaging Leader Reports Record-Breaking Demand for Gadoterate Meglumine Injection

December 7, 2021 — Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging, announced a recent boom ...

Time December 07, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now